Hansa Biopharma AB (HNSA) Income Statement

Last quarter (Q4 2024), Hansa Biopharma AB's total revenue was kr32.34M, a decrease of -35.85% from the same quarter last year. In Q4, Hansa Biopharma AB's net income was kr-276.42M. See Hansa Biopharma AB’s key income statements, including revenue, expenses, profit, and income.